Dalton Greiner Hartman Maher & Co. boosted its stake in shares of Innophos Holdings, Inc. (NASDAQ:IPHS) by 4.5% in the fourth quarter, HoldingsChannel reports. The firm owned 120,007 shares of the specialty chemicals company’s stock after purchasing an additional 5,166 shares during the quarter. Dalton Greiner Hartman Maher & Co.’s holdings in Innophos were worth $3,838,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors also recently added to or reduced their stakes in IPHS. Foundry Partners LLC acquired a new position in Innophos during the 3rd quarter valued at approximately $4,417,000. Nuveen Asset Management LLC acquired a new position in Innophos during the 2nd quarter valued at approximately $2,197,000. Vanguard Group Inc. boosted its position in Innophos by 2.0% during the 2nd quarter. Vanguard Group Inc. now owns 2,160,323 shares of the specialty chemicals company’s stock valued at $62,887,000 after purchasing an additional 42,356 shares during the period. Bank of New York Mellon Corp boosted its position in Innophos by 7.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 545,798 shares of the specialty chemicals company’s stock valued at $15,888,000 after purchasing an additional 37,042 shares during the period. Finally, Millennium Management LLC boosted its position in Innophos by 69.9% during the 3rd quarter. Millennium Management LLC now owns 83,852 shares of the specialty chemicals company’s stock valued at $2,721,000 after purchasing an additional 34,509 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.
Shares of Innophos stock opened at $31.94 on Thursday. The business’s fifty day moving average price is $31.92 and its two-hundred day moving average price is $30.52. The company has a debt-to-equity ratio of 1.01, a current ratio of 2.94 and a quick ratio of 1.48. The company has a market capitalization of $628.73 million, a P/E ratio of 14.01 and a beta of 1.44. Innophos Holdings, Inc. has a 1-year low of $23.85 and a 1-year high of $37.53.
Innophos (NASDAQ:IPHS) last announced its earnings results on Wednesday, November 6th. The specialty chemicals company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.10). The business had revenue of $189.00 million for the quarter, compared to the consensus estimate of $185.55 million. Innophos had a net margin of 2.82% and a return on equity of 11.56%. The firm’s revenue was down 4.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.58 EPS. On average, research analysts expect that Innophos Holdings, Inc. will post 2.05 earnings per share for the current fiscal year.
A number of research firms recently issued reports on IPHS. BidaskClub lowered Innophos from a “sell” rating to a “strong sell” rating in a research report on Saturday, January 11th. Zacks Investment Research upgraded Innophos from a “sell” rating to a “hold” rating in a research report on Wednesday, January 1st. Finally, ValuEngine raised Innophos from a “strong sell” rating to a “sell” rating in a research note on Tuesday. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $36.00.
In other Innophos news, Director John M. Steitz sold 12,625 shares of Innophos stock in a transaction on Friday, December 13th. The stock was sold at an average price of $31.86, for a total transaction of $402,232.50. Following the sale, the director now owns 18,103 shares of the company’s stock, valued at approximately $576,761.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.50% of the stock is owned by insiders.
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Recommended Story: Purposes and Functions of the Federal Reserve
Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.